Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 12, 2023 (Week 32)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 16,054 37,568 877,509 1,133,812
New England 198 1,650 23,864 32,244
Connecticut - 430 1,155 7,560
Maine 55 77 1,804 1,972
Massachusetts - 709 15,463 17,268
New Hampshire 52 82 1,637 1,784
Rhode Island 75 694 2,974 2,889
Vermont 16 37 831 771
Middle Atlantic 2,278 4,218 118,037 118,056
New Jersey 525 788 20,929 20,373
New York (excluding New York City) 874 1,032 25,281 24,229
New York City - 1,457 38,864 39,574
Pennsylvania 879 1,233 32,963 33,880
East North Central 1,808 5,878 114,993 174,729
Illinois - 1,811 29,672 43,771
Indiana 369 858 17,441 20,776
Michigan 313 975 19,769 26,124
Ohio 698 2,294 32,787 67,928
Wisconsin 428 561 15,324 16,130
West North Central 867 2,153 56,103 62,541
Iowa 165 334 8,289 9,096
Kansas 79 325 5,897 8,707
Minnesota 115 497 13,079 13,729
Missouri 508 729 19,331 19,710
Nebraska - 220 4,902 5,964
North Dakota - 92 1,762 2,190
South Dakota - 125 2,843 3,145
South Atlantic 4,345 7,249 200,357 211,282
Delaware 94 420 3,492 6,360
District of Columbia - 191 3,996 4,954
Florida 1,853 2,786 67,234 65,106
Georgia 844 1,597 42,642 45,108
Maryland U NC U U
North Carolina - 1,440 34,216 40,189
South Carolina 747 766 20,507 22,395
Virginia 784 976 25,654 24,376
West Virginia 23 104 2,616 2,794
East South Central 935 2,450 60,618 68,711
Alabama 626 972 21,185 18,884
Kentucky 309 555 9,973 11,130
Mississippi - 488 10,158 14,677
Tennessee - 1,094 19,302 24,020
West South Central 876 5,323 99,400 156,543
Arkansas 211 804 9,844 22,197
Louisiana 570 794 21,795 22,663
Oklahoma - 451 6,397 12,791
Texas 95 3,399 61,364 98,892
Mountain 1,519 2,523 63,499 72,344
Arizona 517 918 24,366 25,455
Colorado 518 765 16,079 15,982
Idaho 1 155 3,426 3,487
Montana 42 100 1,799 2,566
Nevada 193 367 4,659 9,955
New Mexico 13 257 5,338 6,936
Utah 206 252 6,835 6,922
Wyoming 29 54 997 1,041
Pacific 3,228 7,823 140,638 237,362
Alaska 62 121 2,492 3,351
California 2,381 6,833 116,573 202,672
Hawaii - 142 - 3,383
Oregon 383 362 9,310 9,699
Washington 402 635 12,263 18,257
U.S. Territories - 124 1,138 2,880
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 2,880
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 7 38 89
Total 16,055 37,668 878,685 1,136,781
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.